Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3b, Open-Label, Single-Group Immunogenicity and Safety Study of Topical Recombinant Thrombin (rThrombin) in Surgical Hemostasis

NCT00491608 is registered in ClinicalTrials.gov with ZymoGenetics as lead sponsor.

NCT NCT00491608
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00491608 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3b, Open-Label, Single-Group Immunogenicity and Safety Study of Topical Recombinant Thrombin (rThrombin) in Surgical Hemostasis
Lead sponsor
ZymoGenetics
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2007
Completion date
July 31, 2008
Enrollment
234 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

spinal surgery, vascular surgery